Publication | Closed Access

In vivo relevant mixed urolithins and ellagic acid inhibit phenotypic and molecular colon cancer stem cell features: A new potentiality for ellagitannin metabolites against cancer

MedicinePharmacologyNew PotentialityColorectal CancerAnti-cancer AgentEllagitannin MetabolitesOncologyCell BiologyCancer Research